Editor's letter

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

The cell and gene therapy (CGT) space continues to generate a lot of buzz. Amid ongoing funding challenges and getting clinical trials off the ground for Western biotechs, China is emerging as a dominant leader in the space.

This month's cover feature examines the factors propelling China to become a leader of the pack in CGT  amid a challenging global funding environment.

Also in this issue, we examine what impact the Trump administration distancing itself from mRNA technology could end up having on promising cancer vaccines over time.

As regulators push to phase out animal testing, this month's interview sheds light on how the transition to alternative approaches may play out.

All this and the latest pharma industry news, comment, and analysis from GlobalData.

Ross Law, deputy editor